Key result
Transverse myelitis in primary APS presents complex features requiring predictive biomarkers and personalized therapies.
Answers are grounded in this paper and cite their sources.
Supports personalized management of TM in primary APS; extends evidence by prioritizing predictive biomarker development.
Identify literature describing transverse myelitis in primary antiphospholipid syndrome, aiming to characterize its clinical spectrum, immunological features, and therapeutic responses.
No takes yet. Share an insight, caveat, or question.
Tejada et al. (2026) studied this question. Transverse myelitis in primary antiphospholipid syndrome presents complex clinical and immunological features that require predictive biomarkers and personalized therapeutics.
Synapse has enriched 10 related papers. Consider them for comparative context: